The high expression of bone morphogenic protein 2 (BMP2) has been reported in NSCLC (Langenfeld et al., 2003, 2005; Bieniasz et al., 2009; Choi et al., 2012; Fei et al., 2013). This evidence concerns the gene BMP2 and non-small cell lung carcinoma.